TY  - GEN
AU  - Wei,Zheng
AU  - Zou,Shanhua
AU  - Li,Feng
AU  - Cheng,Zhixiang
AU  - Li,Junmin
AU  - Wang,Jianmin
AU  - Wang,Chun
AU  - Chen,Fangyuan
AU  - Cao,Junning
AU  - Cheng,Yunfeng
TI  - HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China
SN  - 1559-131X
PY  - 2014///0930
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - China
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Hepatitis B
KW  - complications
KW  - Hepatitis B Surface Antigens
KW  - metabolism
KW  - Hepatitis B virus
KW  - genetics
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Prednisone
KW  - Prognosis
KW  - Retrospective Studies
KW  - Rituximab
KW  - Survival Rate
KW  - Vincristine
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s12032-014-0845-3
ER  -